Two Sigma Securities’s ABVC BioPharma ABVC Stock Holding History

Two Sigma Securities’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,023	Closed	-$20.4K	–	1675
2026 Q1	$20.4K	Buy	+21,023	New	+$34.8K	﹤0.01%	1370
2025 Q2	–	Sell	-11,470	Closed	-$12.2K	–	1442
2025 Q1	$12.2K	Sell	11,470 -1,123	-9%	-$682	﹤0.01%	1196
2024 Q4	$7.43K	Buy	12,593 +196	+2%	+$109	﹤0.01%	1460
2024 Q3	$8.47K	Buy	+12,397	New	+$8.95K	﹤0.01%	2619
2023 Q2	–	Sell	-2,107	Closed	-$13.5K	–	2725
2023 Q1	$13.5K	Buy	+2,107	New	+$15.1K	﹤0.01%	2414

Other funds holding ABVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Securities's ABVC Position: Q2 2026 in Review

Two Sigma Securities sold out of ABVC BioPharma (ABVC) in Q2 2026, closing a stake of 21,023 shares — an estimated $20.4K sold.

Two Sigma Securities first reported a position in ABVC in Q1 2023 and held it in 5 quarters. The position peaked at $20.4K in Q1 2026. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

Two Sigma Securities reported no remaining ABVC BioPharma position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 21,023 ABVC BioPharma shares in Q2 2026, an estimated $20.4K.
Two Sigma Securities first reported a position in ABVC BioPharma in Q1 2023 and held it in 5 quarters.
Two Sigma Securities's ABVC BioPharma position peaked at $20.4K in Q1 2026.
15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.